Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 10910 Download: 192 Citations: 19

3

Efficacy of Lamivudine Re-treatment and Relapse Patterns after Initial Lamivudine Treatment for Chronic Hepatitis B Infection

Jong Ho Park, M.D., Neung Hwa Park, M.D., Jung Woo Shin, M.D., Sung-Jo Bang, M.D., Dae-Hyun Kim, M.D., Kwang Ro Joo, M.D. and Do Ha Kim, M.D.

Clin Mol Hepatol. 2003;9(3):188-197. Published online January 1, 1970

View: 2100 Download: 13

Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Diseases

In Du Jeong , Neung Hwa Park , Byung Chul Kim , Jee Hyun Park , Kwang Won Seo , Dae Hyun Kim , Kwang Ro Joo , Do Ha Kim

Clin Mol Hepatol. 2003;9(2):69-78. Published online January 1, 1970

View: 2359 Download: 11

The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection

Neung Hwa Park,Kwang Ro Joo,Do Ha Kim

Clin Mol Hepatol. 2001;7(1):77-89. Published online January 1, 2000

View: 2141 Download: 20

1 |

Viewed By 5609	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3575	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3244	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2698	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2606	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology

Cited By 88	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 33	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search